+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (December 2004)

  • ID: 656044
  • Report
  • December 2004
  • 44 pages
  • Mergent
1 of 4
This report discusses the biotechnology sectors in the Asia-Pacific, focusing on Australia, China and Hong Kong, India, Japan, South Korea and Taiwan
Current Environment - Key Points
- Most Asia-Pacific governments still view the biotechnology sector as having great growth potential
- Most governments are keen to foster R&D to acquire patents
However, the region still lacks sufficient intellectual property right protection for drug innovation compared with developed countries
- Asia-Pacific countries are mostly concentrating on bio-pharmaceutical, bio-medicine, and bio- agriculture, especially genetically modified organisms (GMO)
- Food research continues to be a priority, with the region home to more than half the world's population
- With the acceptance of bio-related products in the region, the industry reported improved financial results in 2004
- Although the bio-pharmaceutical industry carries high-risk, it is one of the fastest growing sectors in the region
This is especially the case in India and Korea
Industry Profile - Key Points - Most countries in Asia-Pacific have industry development plans, which set ambitious targets for industry growth, typically either by developing research and its commercialization or by promoting specific market segments
- With the region forecast to be home to ten billion people in 2030, biotechnology development is aimed at increasing agricultural yield to sustain the growing population
- The environment for nurturing the bio-medical industry is becoming more mature globally, but the Asian scene is still in its early stages of growth
- Asia-Pacific countries are now more proactive in upgrading their biotechnology sectors and there continues to be a surge of interest in biotechnology, with numerous conferences held across the region
Market Trends and Outlook - Key Points
- A ban on stem cell research by most European countries and North America (except the state of California) has led to companies and researchers depending on opportunities in Asia-Pacific
- Many developing nations in Asia-Pacific, where agriculture is the main income source, are subjected to the fluctuation of global cereal prices
Biotechnology-aided crops can help stabilize harvests, providing Asian countries with steadier income
- The IT spending for bioscience in Asia-Pacific is likely to exceed US$2.5 billion by 2006, compared with less than US$1 billion in 2003
- The Asia-Pacific biotechnology industry is likely to reach US$30 billion by 2005 excluding Japan

Note: Product cover images may vary from those shown
2 of 4


3 of 4
Current Environment
- Sector Overview
- Sector Performance
- Bio-Agriculture/GMO
- Bio-Medical/Bio-
- Share Performance
- Leading Companies
Industry Profile
- Industry Size and Value
- Areas of Focus
- Agricultural Needs
- Health Needs
- Research and Development
- Government Policy and
Industry Development
- Government Investment
- Venture Capital Investment
Market Trends and Outlook
- Stem Cell Research Shifts
- Demand Grows for Improved
Agricultural Yields
- Leveraging IT to Generate
- Market Outlook
Country Profiles
- Australia
- China and Hong Kong
- India
- Japan
- Korea
- Taiwan
Currency Conversion Table
The Scope of this Report
Key References
Comparative Data
Sales Contacts

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown